// App-Quantinova.ai

404 : Development of a RSPO3 CLIA-validated assay as a predictive biomarker for response to anti-RSPO3 antibody treatment in patients with solid tumors

Researchers

Presenter

  • Chun Zhang

Principal Investigators

  • Min Wang

  • Gilbert OYoung

  • Joy Kavanagh

  • Cheryl McFarlane

  • Fiore Cattaruzza

  • Pete Yeung

  • Jennifer Cain

  • Wan-Ching Yen

  • Marcus Fischer

  • Belinda Cancilla

  • Edwina Dobbin

  • Michelle McCarthy

  • Austin Gurney

  • Leonardo Faoro

  • John Lewicki

  • Tim Hoey

  • Ann M. Kapoun

Medical Centers

  • OncoMed Pharmaceuticals Inc., Redwood City, CA

  • Almac Diagnostics Ltd., Craigavon, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • Almac Diagnostic Ser

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved